Eton Pharmaceuticals, Inc.
ETON
$17.19
-$0.27-1.55%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.59M | -1.57M | -598.00K | 627.00K | -3.04M |
| Total Depreciation and Amortization | 1.01M | 1.01M | 355.00K | 278.00K | 279.00K |
| Total Amortization of Deferred Charges | 78.00K | 294.00K | 986.00K | 39.00K | 59.00K |
| Total Other Non-Cash Items | 3.29M | 2.36M | 852.00K | 722.00K | 822.00K |
| Change in Net Operating Assets | 6.18M | -4.00K | -2.36M | 1.29M | 3.14M |
| Cash from Operations | 7.96M | 2.09M | -765.00K | 2.95M | 1.26M |
| Capital Expenditure | -- | -- | -12.00K | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -30.00M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -8.12M | 0.00 | 0.00 |
| Cash from Investing | -- | -- | -38.13M | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | 25.31M | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | -385.00K | -385.00K |
| Issuance of Common Stock | 0.00 | 394.00K | 8.26M | 0.00 | 169.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 394.00K | 33.57M | -385.00K | -216.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.96M | 2.48M | -5.33M | 2.57M | 1.04M |